Clomethiazole inhibits cytochrome P450 2E1 and improves alcoholic liver disease

Gut ◽  
2021 ◽  
pp. gutjnl-2021-324727
Author(s):  
Nicolas Hohmann ◽  
Fabian Schröder ◽  
Bernardo Moreira ◽  
Haidong Teng ◽  
Jürgen Burhenne ◽  
...  
2009 ◽  
Vol 47 (01) ◽  
Author(s):  
Y Wang ◽  
G Millonig ◽  
J Nair ◽  
H Bartsch ◽  
E Patsenker ◽  
...  

2009 ◽  
Vol 50 ◽  
pp. S264
Author(s):  
Y. Wang ◽  
G. Millonig ◽  
J. Nair ◽  
E. Patsenker ◽  
F. Stickel ◽  
...  

2009 ◽  
Vol 47 (09) ◽  
Author(s):  
G Millonig ◽  
Y Wang ◽  
J Nair ◽  
E Patsenker ◽  
F Stickel ◽  
...  

1997 ◽  
Vol 26 (1) ◽  
pp. 55-61 ◽  
Author(s):  
Vesa T. Savolainen ◽  
Jarkko Pajarinen ◽  
Markus Perola ◽  
Antti Penttilä ◽  
Pekka J. Karhunen

2018 ◽  
Vol 32 (6) ◽  
pp. 3278-3288 ◽  
Author(s):  
Maria Lauda Tomasi ◽  
Komal Ramani ◽  
Minjung Ryoo ◽  
Carla Cossu ◽  
Andrea Floris ◽  
...  

Cells ◽  
2022 ◽  
Vol 11 (2) ◽  
pp. 288
Author(s):  
Julie Massart ◽  
Karima Begriche ◽  
Jessica H. Hartman ◽  
Bernard Fromenty

Cytochrome P450 2E1 (CYP2E1) is pivotal in hepatotoxicity induced by alcohol abuse and different xenobiotics. In this setting, CYP2E1 generates reactive metabolites inducing oxidative stress, mitochondrial dysfunction and cell death. In addition, this enzyme appears to play a role in the progression of obesity-related fatty liver to nonalcoholic steatohepatitis. Indeed, increased CYP2E1 activity in nonalcoholic fatty liver disease (NAFLD) is deemed to induce reactive oxygen species overproduction, which in turn triggers oxidative stress, necroinflammation and fibrosis. In 1997, Avadhani’s group reported for the first time the presence of CYP2E1 in rat liver mitochondria, and subsequent investigations by other groups confirmed that mitochondrial CYP2E1 (mtCYP2E1) could be found in different experimental models. In this review, we first recall the main features of CYP2E1 including its role in the biotransformation of endogenous and exogenous molecules, the regulation of its expression and activity and its involvement in different liver diseases. Then, we present the current knowledge on the physiological role of mtCYP2E1, its contribution to xenobiotic biotransformation as well as the mechanism and regulation of CYP2E1 targeting to mitochondria. Finally, we discuss experimental investigations suggesting that mtCYP2E1 could have a role in alcohol-associated liver disease, xenobiotic-induced hepatotoxicity and NAFLD.


Biomedicines ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 50 ◽  
Author(s):  
Yanchao Jiang ◽  
Ting Zhang ◽  
Praveen Kusumanchi ◽  
Sen Han ◽  
Zhihong Yang ◽  
...  

Once ingested, most of the alcohol is metabolized in the liver by alcohol dehydrogenase to acetaldehyde. Two additional pathways of acetaldehyde generation are by microsomal ethanol oxidizing system (cytochrome P450 2E1) and catalase. Acetaldehyde can form adducts which can interfere with cellular function, leading to alcohol-induced liver injury. The variants of alcohol metabolizing genes encode enzymes with varied kinetic properties and result in the different rate of alcohol elimination and acetaldehyde generation. Allelic variants of these genes with higher enzymatic activity are believed to be able to modify susceptibility to alcohol-induced liver injury; however, the human studies on the association of these variants and alcohol-associated liver disease are inconclusive. In addition to acetaldehyde, the shift in the redox state during alcohol elimination may also link to other pathways resulting in activation of downstream signaling leading to liver injury.


Sign in / Sign up

Export Citation Format

Share Document